Morfeo

Morfeo Uses, Dosage, Side Effects, Food Interaction and all others data.

Morfeo, a pyrazolopyrimidine, is a sedative and hypnotic agent structurally unrelated to the benzodiazepines and other sedative-hypnotic agents. It is shown to interact with GABA subtype A complex by binding selectively to benzodiazepine type 1 receptor. It reduces sleep latency without affecting sleep duration.

Morfeo is a nonbenzodiazepine hypnotic from the pyrazolopyrimidine class and is indicated for the short-term treatment of insomnia. While Morfeo is a hypnotic agent with a chemical structure unrelated to benzodiazepines, barbiturates, or other drugs with known hypnotic properties, it interacts with the gamma-aminobutyric acid-benzodiazepine (GABABZ) receptor complex. Subunit modulation of the GABABZ receptor chloride channel macromolecular complex is hypothesized to be responsible for some of the pharmacological properties of benzodiazepines, which include sedative, anxiolytic, muscle relaxant, and anticonvulsive effects in animal models. Morfeo also binds selectively to the CNS GABAA-receptor chloride ionophore complex at benzodiazepine(BZ) omega-1 (BZ1, ο1) receptors.

Trade Name Morfeo
Availability Prescription only
Generic Zaleplon
Zaleplon Other Names Zaleplon
Related Drugs amitriptyline, lorazepam, melatonin, zolpidem, diphenhydramine, Ativan
Type
Formula C17H15N5O
Weight Average: 305.3339
Monoisotopic: 305.127660127
Protein binding

Approximately 60% (in vitro plasma protein binding).

Groups Approved, Illicit, Investigational
Therapeutic Class Benzodiazepine hypnotics, Benzodiazepine sedatives
Manufacturer
Available Country Poland
Last Updated: September 19, 2023 at 7:00 am
Morfeo
Morfeo

Uses

Morfeo is used for the short-term treatment of insomnia. Morfeo has been shown to decrease the time to sleep onset for up to 30 days in controlled clinical trials.

Morfeo is also used to associated treatment for these conditions: Insomnia

How Morfeo works

Morfeo exerts its action through subunit modulation of the GABABZ receptor chloride channel macromolecular complex. Morfeo also binds selectively to the brain omega-1 receptor located on the alpha subunit of the GABA-A/chloride ion channel receptor complex and potentiates t-butyl-bicyclophosphorothionate (TBPS) binding.

Dosage

Morfeo dosage

The dose of Morfeo should be individualized. The recommended dose of Morfeo for most non elderly adults is 10 mg. For certain low weight individuals, 5 mg may be a sufficient dose. Although the risk of certain adverse events associated with the use of Morfeo appears to be dose dependent, the 20 mg dose has been shown to be adequately tolerated and may be considered for occasional patient who does not benefit from a trial of lower dose. Dosage above 20 mg has not been adequately evaluated and is not recommended.Morfeo should be taken immediately before bedtime. Taking Morfeo with or immediately after a heavy, high fat meal results in slower absorption and would be expected to reduce the effect of Morfeo on sleep latency. Elderly patients and debilitated patients appear to be more sensitive to the effects of hypnotic, and respond to 5 mg of Morfeo. The recommended dose for these patients is therefore 5 mg, doses over 10 mg are not recommended. For patients with mild to moderate renal impairment no dose adjustment is necessary.An initial dose of 5 mg should be given to patients concomitantly taking Cimetidine because ZalMorfeo clearance is reduced in this population.

Side Effects

Side effects of Morfeo appear to be dose related. So, it is important to use the lowest possible effective dose, specially in the elderly. The side effects are usually mild and transient, the most common are diarrhoea, nausea, vomiting, vertigo, headache, asthenia, nightmare etc.

Toxicity

Side effects include abdominal pain, amnesia, dizziness, drowsiness, eye pain, headache, memory loss, menstrual pain, nausea, sleepiness, tingling, weakness

Precaution

Timing of drug administration: Morfeo should be taken immediately before bedtime or after the patient has gone to bed.Use in the elderly and/or debilitated patients: Impaired motor and/or cognitive performance after repeated exposure or unusual sensitivity to sedative/hypnotic drugs is a concern in the treatment of elderly and/or debilitated patients. A dose of 5 mg is recommended for elderly patients to decrease the possibility of side effects. Elderly and/or debilitated patients should be monitored closely.Use in patients with concomitant illness: Morfeo should be used with caution in patients with diseases or conditions that could affect metabolism or haemodynamic responses. Although preliminary studies did not reveal respiratory depressant effects at hypnotic doses of Morfeo in normal subjects, caution should be observed if Morfeo is prescribed to patients with compromised respiratory function, because sedative/hypnotic have the capacity to depress respiratory drive. However, patients with compromised respiration due to preexisting illness should be monitored carefully. The dose of Morfeo should be reduced to 5 mg in patients with mild to moderate hepatic impairment. It is not recommended for use in patients with severe hepatic impairment.Renal impairment patients: No dose adjustment is necessary in patients with mild to moderate renal impairment. Morfeo has not been adequately studied in patients with severe renal impairment.Use in patients with depression: As with other sedative or hypnotic drugs, Morfeo should be administered with caution to patients exhibiting signs or symptoms of depression

Interaction

Morfeo has been shown to have minimal effects on the kinetic of Warfarin, Imipramine, Ethanol, Ibuprofen, Diphenhydramine, Thioridazine, and Digoxin.

Food Interaction

  • Avoid alcohol. Ingesting alcohol may increase the CNS depressant effects of zaleplon.
  • Do not take with or immediately after a high-fat meal. The effects of zaleplon are reduced when taken with a high-fat meal.

[Moderate] GENERALLY AVOID: Alcohol may potentiate some of the pharmacologic effects of zaleplon.

Use in combination may result in additive central nervous system depression and
ADJUST DOSING INTERVAL: Administration of zaleplon with a high-fat or heavy meal may delay the onset of hypnotic effects.

In healthy adult subjects, administration of zaleplon with a high-fat meal resulted in a 2-hour delay in the time to reach peak plasma drug concentration (Tmax) and a 35% reduction in the peak plasma drug concentration (Cmax) compared to fasting.

Morfeo systemic exposure (AUC) and elimination half-life were not significantly affected.

MANAGEMENT: Patients receiving zaleplon should be advised to avoid the consumption of alcohol.

For faster sleep onset, zaleplon should not be administered with or immediately after a high-fat or heavy meal.

Volume of Distribution

  • 1.4 L/kg

Elimination Route

Absorption Morfeo is rapidly and almost completely absorbed following oral administration.

Half Life

Approximately 1 hour

Clearance

  • 1 L/h/kg

Elimination Route

Morfeo is metabolized primarily by the liver and undergoes significant presystemic metabolism. After oral administration, zaleplon is extensively metabolized, with less than 1% of the dose excreted unchanged in urine. Renal excretion of unchanged zaleplon accounts for less than 1% of the administered dose.

Pregnancy & Breastfeeding use

Pregnancy: There are no studies of Morfeo in pregnant women; therefore, it is not recommended for use in women during pregnancy. Morfeo has no established use in labour and delivery.Lactation: A study in lactating mothers indicated that the clearance and half-life of Morfeo is similar to that in young normal subjects. A small amount of Morfeo is excreted in breast milk, with the highest excreted amount occurring during a feeding at approximately 1 hour after Morfeo administration. Since the small amount of the drug from breast milk may result in potentially important concentrations in infants, and because the effects of Morfeo on a nursing infant are not known, it is not recommended in nursing mothers.

Contraindication

Morfeo is contraindicated in patients with known hypersensitivity to any of its components.

Special Warning

Special Patient Group: Patients on cimetidine should receive initial dose of 5 mg at bedtime.Hepatic Impairment:

  • Mild to moderate: 5 mg at bedtime.
  • Severe: Contraindicated.

Paediatric use

: The safety and effectiveness of Morfeo in paediatric patients have not been established.

Innovators Monograph

You find simplified version here Morfeo

Morfeo contains Zaleplon see full prescribing information from innovator Morfeo Monograph, Morfeo MSDS, Morfeo FDA label

FAQ

What is Morfeo used for?

Morfeo is used on a short-term basis to treat insomnia (difficulty falling asleep).Morfeo does not help you to stay asleep longer or decrease the number of times that you awaken during the night. .

What type of the Morfeo?

Morfeo is in a class of medications called hypnotics. It works by slowing activity in the brain to allow sleep.

What are the side effect of Morfeo?

Morfeo may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

  • drowsiness
  • dizziness
  • lightheadedness
  • lack of coordination
  • numbness, burning, or tingling in the hands or feet
  • headache
  • loss of appetite
  • vision problems
  • eye pain
  • sensitivity to noise
  • distorted sense of smell
  • painful menstrual periods

Can I take Morfeo every night?

You should take Morfeo every night since Morfeo is taken only at bedtime, you will not be on a frequent dosing schedule.

Can I drink alcohol while taking Morfeo?

You should avoid the use of alcohol while being treated with Morfeo. Alcohol can increase the nervous system side effects of Morfeo such as dizziness and drowsiness.

Is Morfeo safe during pregnancy?

Morfeo is not recommended for pregnant women unless the doctor believes the benefits outweigh the potential risks.

is Morfeo safe during breastfeeding?

If a doctor or health visitor says that your baby is healthy, it's safe to take Morfeo while breastfeeding. Morfeo passes into breast milk in very small amounts.

Can I drive after taking Morfeo?

FDA approves new label changes and dosing for Morfeo products and a recommendation to avoid driving the day after using Ambien CR.

Does Morfeo make me tired ?

You may still feel sleepy the morning after taking the medication.

Can I take take on empty stomach?

It is better to take this medicine on an empty stomach and only when you are ready for bed. Do not take your medicine more often than directed

How much Morfeo does it take to overdose?

Individuals have fully recovered from Morfeo overdoses of greater than 200 mg (10 times the maximum recommended dose of Morfeo).

How long does it take for Morfeo to work?

Morfeo takes about 20 to 30 minutes for them to start working.

Does Morfeo cause memory loss?

Dizziness, drowsiness, short-term memory loss, or lack of coordination may occur, especially during the first 2 hours after you take the medication.

Can I take Morfeo for a long time?

Do not take Morfeo for longer than 5 weeks without your doctor's advice.Morfeo is for short-term use only.

*** Taking medicines without doctor's advice can cause long-term problems.
Share